Following are the day’s biggest winners and losers. Find out why shares of Microsoft and Yamana Gold popped while Pepsico and Barnes & Noble dropped.   Read More

Here's our Fast Money Final Trade. Our gang gives you tomorrow's best trades, right now!   Read More

It's the equivalent of slipping a press release with negative news under the door at the close of business on a Friday. But after the closing bell on Yom Kippur, when many people including me were trying to give up food and tweeting for a day, Sequenom tossed a grenade.    Read More

Cramer makes the call on viewers' favorite stocks.   Read More

With rumors flying that SEQureDX data will be released soon, investors are betting that the stock will move in the next four weeks. They are expecting positive news about a Down Syndrome test that caused the shares to tank in late April.   Read More

The Lightning Round is extended in this CNBC.com exclusive feature.   Read More

Sequenom fell by 75 percent overnight in late April after it revealed that some employees had mishandled data and results for its Down syndrome test. The genetic-analysis company fell as low as $2.86 after that debacle, but yesterday its stock rallied back 58 percent.    Read More